BRCA2 and breast carcinoma: Two variants identified in the present study in BRCA2 (BRCA2 c.3482dup and BRCA2 c.8878C>T) have clear diagnostic and clinical relevance, as pathogenic variants in this gene have been proven to increase the risk of breast cancer.